Otitis media vaccine - Intercell

Drug Profile

Otitis media vaccine - Intercell

Alternative Names: Vaccine against middle ear infections - Intercell

Latest Information Update: 09 Mar 2012

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Intercell
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Otitis media; Otorhinolaryngological infections

Most Recent Events

  • 24 Feb 2010 Discontinued - Preclinical for Otitis media in European Union (unspecified route)
  • 24 Feb 2010 Discontinued - Preclinical for Otorhinolaryngological infections in European Union (unspecified route)
  • 19 Nov 2006 Preclinical trials in Otitis media in European Union (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top